The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010

Background Euromelanoma is a skin cancer education and prevention campaign that started in 1999 in Belgium as ‘Melanoma day’. Since 2000, it is active in a large and growing number of European countries under the name Euromelanoma. Objective To evaluate results of Euromelanoma in 2009 and 2010 in...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the European Academy of Dermatology and Venereology Vol. 25; no. 12; pp. 1455 - 1465
Main Authors:	van der Leest, R.J.T., de Vries, E., Bulliard, J-L., Paoli, J., Peris, K., Stratigos, A.J., Trakatelli, M., Maselis, T.J.E.M.L., Šitum, M., Pallouras, A.C., Hercogova, J., Zafirovik, Z., Reusch, M., Olah, J., Bylaite, M., Dittmar, H.C., Scerri, L., Correia, O., Medenica, L., Bartenjev, I., Guillen, C., Cozzio, A., Bogomolets, O.V., del Marmol, V.
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Publishing Ltd 01-12-2011
Subjects:	Belgium - epidemiology Dermatologi och venereologi Dermatology and Venereal Diseases Female Humans Male Melanoma - epidemiology Melanoma - prevention & control Skin Neoplasms - epidemiology Skin Neoplasms - prevention & control Sunlight Surveys and Questionnaires Belgium
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Background Euromelanoma is a skin cancer education and prevention campaign that started in 1999 in Belgium as ‘Melanoma day’. Since 2000, it is active in a large and growing number of European countries under the name Euromelanoma. Objective To evaluate results of Euromelanoma in 2009 and 2010 in 20 countries, describing characteristics of screenees, rates of clinically suspicious lesions for skin cancer and detection rates of melanomas. Methods Euromelanoma questionnaires were used by 20 countries providing their data in a standardized database (Belgium, Croatia, Cyprus, Czech Republic, FYRO Macedonia, Germany, Greece, Hungary, Italy, Lithuania, Luxembourg, Malta, Moldavia, Portugal, Serbia, Slovenia, Spain, Sweden, Switzerland and Ukraine). Results In total, 59 858 subjects were screened in 20 countries. Most screenees were female (64%), median ages were 43 (female) and 46 (male) and 33% had phototype I or II. The suspicion rates ranged from 1.1% to 19.4% for melanoma (average 2.8%), from 0.0% to 10.7% for basal cell carcinoma (average 3.1%) and from 0.0% to 1.8% for squamous cell carcinoma (average 0.4%). The overall positive predictive value of countries where (estimation of) positive predictive value could be determined was 13.0%, melanoma detection rates varied from 0.1% to 1.9%. Dermoscopy was used in 78% of examinations with clinically suspected melanoma; full body skin examination was performed in 72% of the screenees. Conclusion Although the population screened during Euromelanoma was relatively young, high rates of clinically suspected melanoma were found. The efficacy of Euromelanoma could be improved by targeting high‐risk populations and by better use of dermoscopy and full body skin examination.
Bibliography:	ArticleID:JDV4228 ark:/67375/WNG-2LXQTM0R-5 istex:740C1F0F3E580D73914A4D79F710A9A202D4DEDD Funding sources The Euromelanoma campaigns in all participating European countries were sponsored by multiple Dermatological Societies, Cancer Leagues and (Pharmaceutical) companies, specific for each country. Names of sponsors are available through the corresponding author. The database collection and database analysis were not sponsored. appendix Conflicts of interest Euromelanoma group (institutions are listed in the All authors declared no conflicts of interest. . ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0926-9959 1468-3083 1468-3083
DOI:	10.1111/j.1468-3083.2011.04228.x